These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 17888511

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG, Hellström-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J.
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
    Gritsaev SV, Martynkevich IS, Abdulkadyrov KM, Tiranova SA, Kakaĭ MP, Martynenko LS, Dziavgo LA.
    Ter Arkh; 2005 Mar; 77(7):22-7. PubMed ID: 16116904
    [Abstract] [Full Text] [Related]

  • 9. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
    Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C, Passamonti F, Invernizzi R, Castello A, Magrini U, Lazzarino M, Cazzola M.
    J Clin Oncol; 2009 Feb 10; 27(5):754-62. PubMed ID: 19103730
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
    Kao JM, McMillan A, Greenberg PL.
    Am J Hematol; 2008 Oct 10; 83(10):765-70. PubMed ID: 18645988
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
    Chu SC, Wang TF, Li CC, Kao RH, Li DK, Su YC, Wells DA, Loken MR.
    Leuk Res; 2011 Jul 10; 35(7):868-73. PubMed ID: 21397943
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The International Prognostic Scoring System for primary myelodysplastic syndrome].
    Sisková M, Dohnalová A, Neuwirtová R, Pĕnicková J, Karban J, Cmunt E.
    Sb Lek; 2002 Jul 10; 103(3):333-8. PubMed ID: 12688177
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes.
    Wang H, Wang X, Xu X, Lin G.
    Ann Hematol; 2010 Jul 10; 89(7):671-9. PubMed ID: 20179929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.